Covid-19 Vaccines — Immunity, Variants, Boosters | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Objectives To synthesise evidence on incidence rates and risk factors for myocarditis and
pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term …

Background: Cases of adolescents and young adults developing myocarditis after
vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–targeted …

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Cases of myocarditis, diagnosed clinically by laboratory tests and imaging have been
described in the context of mRNA-based anti-SARS-CoV-2 vaccination. Autopsy-based …

Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

Predictions for a near end of the pandemic by the World Health Organization should be
interpreted with caution. Current evidence indicates that the efficacy of a fourth dose of …

Aims To explore the incidence and potential mechanisms of oligosymptomatic myocardial
injury following COVID‐19 mRNA booster vaccination. Methods and results Hospital …

The COVID-19 pandemic triggered a sense of vulnerability and urgency that led to
concerted actions by governments, funders, regulators and industry to overcome traditional …

Introduction There have been reports of potential negative cardiovascular effects from the
COVID-19 vaccine, such as myocarditis or pericarditis. This study sought to ascertain the risk …